J Melo. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Active Transport, Cell Nucleus/drug effectsAnimalsApoptosisBenzamidesCell Nucleus/metabolismEnzyme Inhibitors/pharmacologyFatty Acids, Unsaturated/pharmacologyFusion Proteins, bcr-abl/geneticsFusion Proteins, bcr-abl/metabolismHumansImatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyPiperazines/pharmacologyProtein-Tyrosine Kinases/antagonists & inhibitorsPyrimidines/pharmacologyTumor Cells, Cultured
Substances: See more » BenzamidesEnzyme InhibitorsFatty Acids, UnsaturatedPiperazinesPyrimidinesImatinib MesylateProtein-Tyrosine KinasesFusion Proteins, bcr-ablleptomycin B
Year: 2001 PMID: 11175841 DOI: 10.1038/84591
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440